基于改良UPOINT(S)系统的个体化治疗对CP/CPPS合并SD患者的疗效分析

扫码查看

原文链接

万方数据
维普

中文摘要：目的基于改良UPOINT(S)临床表现分型系统,对慢性前列腺炎/慢性盆腔疼痛综合征(CP/CPPS)合并以勃起功能障碍(ED)、早泄(PE)为代表的性功能障碍(SD)患者采用以临床症状为导向的标准化诊断和个体化治疗,验证其临床疗效,并为选择临床治疗方案提供依据.方法选取2018年1月至2021年12月中国人民解放军联勤保障部队第九四○医院门诊治疗的160例CP/CPPS合并以ED和/或PE为代表的SD患者作为研究对象,随机分为常规药物治疗的对照组(n=53)、基于传统UPOINT临床表现分型系统指导治疗的传统组(n=49)和基于改良UPOINT(S)临床表现分型系统指导治疗的改良组(n=58).根据各组治疗前后美国国立卫生研究院慢性前列腺炎症状指数(NIH-CPSI)评分、最大尿流率(Qmax)、视觉模拟评分法(VAS)评分、国际勃起功能指数5(IIEF-5)评分、中国早泄患者性功能评分表(C-ISFPE)评分、前列腺液中白细胞(EPS-WBC)计数的变化,评价三组临床疗效差异.结果治疗前三组临床资料差异均无统计学意义(P＞0.05).治疗后,与对照组比较,传统组和改良组在所有指标上均改善显著,差异均具有统计学意义(P＜0.05);与传统组比较,改良组在治疗ED[IIEF-5评分(22.0±1.2)分 vs.(19.8±2.0)分,P=0.006]和 PE[C-ISFPE 评分(25.5±1.8)分 vs.(19.5±2.2)分,P=0.005]方面改善更加显著,差异均具有统计学意义(P＜0.05).结论基于改良UPOINT(S)临床表现分型系统指导的个体化治疗,可显著改善CP/CPPS合并SD患者的性功能异常状况,相较于常规治疗和基于传统UPOINT临床表现分型系统指导治疗的疗效更好.

外文标题：Curative effect analysis of individualized treatment based on UPOINT(S)phenotype classification system in chronic prostatitis/chronic pelvic pain syndrome combined with sexual dysfunction patients

外文摘要：Objective To verify the clinical efficacy of chronic prostatitis/chronic pelvic pain syndrome(CP/CPPS)patients combined with sexual dysfunction(SD)represented by erectile dysfunction(ED)and/or premature ejaculation(PE)receiving clinical symptom-oriented standardized diagnosis and individualized treatment based on the UPOINT(S)phenotype classification system,and to provide a basis for selecting clinical treatment options.Methods A total of 160 CP/CPPS patients combined with SD represented by ED and/or PE in outpatient clinics of the 940th Hospital of Joint Logistics Support Force of Chinese People's Liberation Army from January 2018 to December 2021 were selected as study objects and randomly divided into a control group for conventional drug therapy(n=53),a traditional group with guided treatment based on the traditional UPOINT phenotype classification system(n=49),an improvement group with guided treatment based on the improved UPOINT(S)phenotype classification system(n=58).According to the changes in National Institutes of Health chronic prostatitis symptom index(NIH-CPSI),maximum urinary flow rate(Qmax),visual analogue scale(VAS),international index of erectile function-5(IIEF-5),Chinese index of sexual function for premature ejaculation(C-ISFPE),and expressed prostatic secretion white blood cell count(EPS-WBC)before and after treatment,the differences in clinical efficacy between the three groups were evaluated.Results There was no statistical difference in clinical data in three groups of treatment(P＞0.05).After treatment,the traditional group and the improvement group improved in all indicators compared with the control group,with statistical differences(P＜0.05);compared with the traditional group,the improvement group improved more significantly in treatment of ED(IIEF-5 score:22.0±1.2 vs.19.8±2.0,P=0.006)and PE(C-ISFPE score:25.5±1.8 vs.19.5±2.2,P=0.005),with statistically significant differences(P＜0.05).Conclusions Individualized treatment based on the UPOINT(S)phenotype classification system can significantly improve the abnormal sexual function status of CP/CPPS patients combined with SD,and has better efficacy compared with conventional treatment and treatment based on traditional UPOINT phenotype classification system.

外文关键词：

Chronic prostatitis/chronic pelvic pain syndromeSexual dysfunctionUPOINT(S)phenotype classification systemUPOINT phenotype classification systemBiofeedbackLow-frequency pulse electrical stimulationEfficacy

作者：

徐柳汀、张斌、苗鹏程、康印东、吴悠悠、常德辉

展开 >

作者单位：

中国人民解放军联勤保障部队第九四○医院泌尿外科/全军泌尿外科中心,兰州 730050

中国人民解放军联勤保障部队第九四○医院内分泌科,兰州 730050

关键词：

慢性前列腺炎/慢性盆腔疼痛综合征性功能障碍改良UPOINT(S)临床表现分型系统 UPOINT临床表现分型系统生物电反馈低频脉冲电刺激疗效

基金：

军队保健专项科研课题军队计生专项科研课题940医院院内专项培育项目甘肃省自然科学基金项目

项目编号：

21BJZ4321JSZ132021yxky01722JR5RA001

出版年：

2024

DOI：

10.3969/j.issn.1672-1993.2024.10.004

中国性科学

中国性学会

中国性科学

CSTPCD

影响因子：1.394

ISSN：1672-1993

年,卷(期)：2024.33(10)